Portfolio Building Block World Pharma and Biotech Index ETF (PBPH)
ETF overview
The Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) is designed to give investors specific exposure to the worldwide pharmaceutical and biotechnology sectors. These are recognized as some of the most rapidly evolving and research-intensive fields within healthcare. The ETF's objective is to emulate the returns of the BITA Global Pharma and Biotech Select Index, which tracks businesses operating in developed markets that generate a significant portion of their earnings from the invention, progression, and sale of treatments for human health.
Fund facts
- Expense ratio
- 0.13%
- Fund assets
- 1.11B USD (all share classes)
- Issuer
- Portfolio Building Block ETFs
- Inception date
- Nov 24, 2025
- Number of holdings
- 52
Breakdown
Holdings (52)
| Name | Ticker | Weight |
|---|---|---|
| ELI LILLY & CO | LLY.TO | 16.08% |
| JOHNSON & JOHNSON | JNJ.TO | 9.29% |
| ABBVIE INC | ABBV | 7.63% |
| MERCK & CO. INC. | MRK | 5.46% |
| ROCHE HOLDING AG | 4.94% | |
| ASTRAZENECA PLC | AZN.L | 4.61% |
| AMGEN INC | AMGN | 4.39% |
| NOVARTIS AG-REG | NVS | 4.20% |
| GILEAD SCIENCES INC | GILD.TO | 4.06% |
| PFIZER INC | PFE.BA | 3.49% |
| and 39 more | ||
Similar ETFs
- iShares U.S. Healthcare ETFIYH · Overlap 59% · Expense ratio 0.37%
- State Street Health Care Select Sector SPDR ETFXLV · Overlap 56% · Expense ratio 0.08%
- iShares Global Healthcare ETFIXJ · Overlap 55% · Expense ratio 0.38%
- Vanguard Health Care ETFVHT · Overlap 53% · Expense ratio 0.09%
- Fidelity MSCI Health Care Index ETFFHLC · Overlap 52% · Expense ratio 0.08%
- First Trust Nasdaq Pharmaceuticals ETFFTXH · Overlap 52% · Expense ratio 0.60%
- BetaShares - Global Healthcare Currency Hedged ETFDRUG.AX · Overlap 58% · Expense ratio 0.57%
- VanEck Pharmaceutical ETFPPH · Overlap 48% · Expense ratio 0.36%
Overlap is the share of assets the two funds hold in common.
Historical returns do not guarantee future returns. This is not investment advice.
Portfolio Building Block World Pharma and Biotech Index ETF (PBPH)
- Expense ratio
- 0.13%
- Fund assets
- 1.11B USD (all share classes)
- Issuer
- Portfolio Building Block ETFs
- Inception date
- Nov 24, 2025
- Number of holdings
- 52
| Name | Ticker | Weight |
|---|---|---|
| ELI LILLY & CO | LLY.TO | 16.08% |
| JOHNSON & JOHNSON | JNJ.TO | 9.29% |
| ABBVIE INC | ABBV | 7.63% |
| MERCK & CO. INC. | MRK | 5.46% |
| ROCHE HOLDING AG | 4.94% | |
| ASTRAZENECA PLC | AZN.L | 4.61% |
| AMGEN INC | AMGN | 4.39% |
| NOVARTIS AG-REG | NVS | 4.20% |
| GILEAD SCIENCES INC | GILD.TO | 4.06% |
| PFIZER INC | PFE.BA | 3.49% |
| and 39 more | ||
The Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) is designed to give investors specific exposure to the worldwide pharmaceutical and biotechnology sectors. These are recognized as some of the most rapidly evolving and research-intensive fields within healthcare. The ETF's objective is to emulate the returns of the BITA Global Pharma and Biotech Select Index, which tracks businesses operating in developed markets that generate a significant portion of their earnings from the invention, progression, and sale of treatments for human health.
- iShares U.S. Healthcare ETFIYH · Overlap 59% · Expense ratio 0.37%
- State Street Health Care Select Sector SPDR ETFXLV · Overlap 56% · Expense ratio 0.08%
- iShares Global Healthcare ETFIXJ · Overlap 55% · Expense ratio 0.38%
- Vanguard Health Care ETFVHT · Overlap 53% · Expense ratio 0.09%
- Fidelity MSCI Health Care Index ETFFHLC · Overlap 52% · Expense ratio 0.08%
- First Trust Nasdaq Pharmaceuticals ETFFTXH · Overlap 52% · Expense ratio 0.60%
- BetaShares - Global Healthcare Currency Hedged ETFDRUG.AX · Overlap 58% · Expense ratio 0.57%
- VanEck Pharmaceutical ETFPPH · Overlap 48% · Expense ratio 0.36%
Overlap is the share of assets the two funds hold in common.
Unlock all ETF data
Sign up for FreeUnlock all ETF data
Sign up for Free